Summit Therapeutics SMMT Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's preferred stock, shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's preferred stock, shares outstanding?
- Summit Therapeutics (SMMT) reported preferred stock, shares outstanding of $0 in Q1 2026.